What is the current Price Target for the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock?

The average Cyclo Therapeutics Inc - Ordinary Shares - Class A target price is $4.00. This is 455.09% higher than the current stock price. 1 Analyst has issued a Cyclo Therapeutics Inc - Ordinary Shares - Class A price target 2026.

What's going on with the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock today?

The performance of Cyclo Therapeutics Inc - Ordinary Shares - Class A stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Cyclo Therapeutics Inc - Ordinary Shares - Class A Forecast, price target & analysts

Q: How high will the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock rise?

No reliable answer can be given as to how high the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock will rise. The performance of stocks, including the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock fall?

The decline in Cyclo Therapeutics Inc - Ordinary Shares - Class A stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$0.72

0.00%

Nasdaq, Wed, Apr 02 2025

ISIN

US23254X2018

Symbol

CYTH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Cyclo Therapeutics Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Cyclo Therapeutics Inc - Ordinary Shares - Class A Classifications & Recommendation:

Hold

100%

Cyclo Therapeutics Inc - Ordinary Shares - Class A Price Target

Target Price	$4.00
Price	$0.72
Potential	455.09% register free of charge
Number of Estimates	1

	1 Analyst has issued a Cyclo Therapeutics Inc - Ordinary Shares - Class A price target 2026. The average Cyclo Therapeutics Inc - Ordinary Shares - Class A target price is $4.00. This is 455.09% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 0 Analysts recommend Cyclo Therapeutics Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of 455.09% register free of charge . Most analysts recommend the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock at Hold.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Revenue Million $	1.08	0.70
	21.74%	35.19%

1 Analyst has issued a sales forecast Cyclo Therapeutics Inc - Ordinary Shares - Class A 2024 . The average Cyclo Therapeutics Inc - Ordinary Shares - Class A sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2023	$1.1m	21.74%
2024	$700k 35.19% Unlock
2025	$500k 28.57% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
EV/Sales		45.57

Based on analysts' sales estimates for 2024, the Cyclo Therapeutics Inc - Ordinary Shares - Class A stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	36.67	24.98%
2024	45.57 24.27% Unlock
2025	63.80 40.00% Unlock

Current	23.70	35.86%
2024	29.46 24.29% Unlock
2025	41.24 40.00% Unlock

Cyclo Therapeutics Inc - Ordinary Shares - Class A...

Current Cyclo Therapeutics Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Aug 27 2024
Ascendiant Capital	Locked ➜ Locked	Locked	Aug 26 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 23 2024

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Aug 27 2024
Locked Ascendiant Capital: Locked ➜ Locked	Aug 26 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 23 2024

Discover more stocks with a high price target

Novo Nordisk 75.12%

Coinbase Global, Inc. 71.30%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now